Certified by Founder Lodge
HepaRegeniX GmbH
Germany - Tübingen , Baden-Württemberg
START UP
1 Disclosed Funding Rounds $24,359,707
0 Participating Investments
-
Founded date
2017
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
HepaRegeniX GmbH is a clinical-stage biotechnology company developing novel therapies for the treatment of acute and chronic liver diseases.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 16 ,2025 | Unknown | $24,359,707 |
Wellington Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Revel(US) | $150,000,000 | (Feb 27, 2026)
Bluprynt | $4,250,000 | (Feb 27, 2026)
VITURE | $100,000,000 | (Feb 27, 2026)
ElastixAI | $18,000,000 | (Feb 27, 2026)
UpGuard | $75,000,000 | (Feb 27, 2026)
